glaxosmithkline plc eu regulators expand use of asthma inhaler glaxosmithkline plc said its asthma inhaler seretide known as advair in the u s can now be used in the european union to treat more patients suffering from chronic obstructive pulmonary disease the company said the inhaler its top seller was granted a license extension by the european drug regulator for use in a broader population of patients suffering from chronic obstructive pulmonary disease 
